Customised Services in Preclinical Inflammation

Publicerad 2020-03-26

Master project available

Successful translation of in vitro results to in vivo proof of concept data is essential in early drug development. Traditionally, in vitro models have had major limitations in predictability but the use of 3D cell cultures, mimicking structures in which cells resides in vivo, increased translatability can be achieved.

We are now, in collaboration with Cellevate, looking for a student interested to take on a master project where new 3D ex vivo models for skin inflammatory diseases will be validated and evaluated for use in early drug discovery.

The project will involve both practical lab work as well as in-depth theory and engineering of 3D nanofiber networks.

Read more in the PDF below and send your application to info@redoxis.com or info@cellevate.com

Contact